Status:
COMPLETED
Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy
Lead Sponsor:
Tanta University
Conditions:
CIN
Cancer of Cervix
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical bi...
Detailed Description
* Study design and settings: Cross sectional descriptive studies conducted from December 2017 till January 2021. * Patients: 80 patients with supracervical hysterectomy recruited at Tanta University H...
Eligibility Criteria
Inclusion
- all symptomatizing patients following supracervical hysterectomy,
Exclusion
- with total hysterectomy,
- hysterectomies for malignant indications,
- refusal to participate.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04809727
Start Date
December 1 2017
End Date
January 31 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ayman Shehata Dawood
Tanta, Gharbia Governorate, Egypt, 31111